3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
14
Terminated
3
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Mycosis Fungoides
3
Multiple Myeloma
3
Neoplasms, Plasma Cell
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, T-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Burkitt Lymphoma
2
Uveal Melanoma
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Advanced Cancers
1
Interventions
Cyclophosphamide
12
Rituximab
10
Peripheral Blood Stem Cell Transplantation
8
fludarabine phosphate
7
Etoposide
5
fludarabine
4
Radiotherapy
4
Filgrastim
4
Cytarabine
4
venetoclax
3
ofatumumab
3
Whole-Body Irradiation
3
Vincristine
3
Tacrolimus
3
Mycophenolic Acid
3
Methotrexate
3
Doxorubicin
3
Cyclosporine
3
Carmustine
3
Bendamustine Hydrochloride
3
sargramostim
2
romidepsin
2
idelalisib
2
ibrutinib
2
ibritumomab tiuxetan
2
Saline Solution
2
Prednisone
2
Pentetic Acid
2
Ondansetron
2
O(6)-benzylguanine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Lymphoma, Non-Hodgkin
×
Vorinostat
×
Clear all
NCT00837174
2017-09-19
COMBOSTAT
The Methodist Hospital Research Institute
Phase 2
Withdrawn